← All Sponsors
SPONSOR

Atsena Therapeutics Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: X-linked Retinoschisis
NCT05878860 Phase 1, Phase 2
Recruiting

ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis

X-linked Retinoschisis
United States View Trial →